# Inovio Pharmaceuticals, Inc.: Form 8-K, filed Jan 25, 2024

- Company: [Inovio Pharmaceuticals, Inc.](/companies/ino.md) (CIK 1055726)
- Form: 8-K
- Filed: 2024-01-25
- Accepted by EDGAR: Jan 25, 2024, 16:02 ET
- Period: 2024-01-24
- Accession: 0001193125-24-015380
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1055726/000119312524015380/d736726d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1055726/000119312524015380/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1055726/000119312524015380/d736726d8k.htm

Filed Jan 25, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-015380. Last ingested by Listed: Nov 6, 2026, 17:27 ET. No prices; not investment advice.